Upload
phamthien
View
213
Download
0
Embed Size (px)
Citation preview
ross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 1 of 21 ichel Perreault, principal investigator
CM
SCREENING OF SUBSTANCE USE PROBLEMS SCREENING ADULTS ALCOHOL AND DRUGS 1) CAGE‐AID (Cut, Annoyed, Guilty, Eye‐Opener – Adapted to include Drugs) modified version of the CAGE screen for alcohol problems, the CAGE‐AID is a four‐item conjoint screen A
for alcohol and substance abuse. Approximate length = 2 mintues.
ing/adult_services/screening.html) Ref : http://www.omh.state.ny.us/omhweb/resources/providers/co_occurrRef: http://www.partnersagainstpain.com/printouts/A7012DA4.pdf) (( SCREENING YOUTHS ALCOHOL AND DRUGS 1) CRAFFT / ADOSPA (Auto/moto – Détente – Oubli – Seul – Problèmes – Amis) Consists of a series of 6 questions developed to screen adolescents for high risk alcohol and other drug use disorders simultaneously. It is a short, effective screening tool meant to assess whether a longer onversation about the context of use, frequency, and other risks and consequences of alcohol and other cdrug use is warranted. Ref : http://www.ceasar‐boston.org/CRAFFT/index.php) Ref : http://www.ceasar‐boston.org/CRAFFT/pdf/CRAFFT_English.pdf) (( ASSESSMENT ADULTS ALCOHOL AND DRUGS 1) ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World ealth Organization (WHO) by an international group of substance abuse researchers to detect and
re settings. Hmanage substance use and related problems in primary and general medical ca Ref : http://www.who.int/substance_abuse/activities/assist/en/index.html) Ref : http://www.who.int/substance_abuse/activities/en/Draft_The_ASSIST_Guidelines.pdf) ((
gram for the South‐West of Montreal, June 1st, 2011 session Page 2 of 21 Michel Perreault, principal investigator
Cross‐training pro
ASSESSMENT ADULTS ALCOHOL AND DRUGS 2) DÉBA‐A/D (Dépistage/Évaluation du Besoin d’Aide – Alcool/Drogues) The DÉBA‐A/D provides an evaluation that can establish an intervention plan for front‐line services. This tools can help orient persons to the appropriate level of service depending on the severity of their consumption : toward services of the front line (CSSS, CLSC) for those presenting a level of consumption that is deemed at risk or problematic, and toward specialized services for those who are deemed abusive or dependent in terms of their consumption (substance abuse readaptation centres). The DÉBA‐A/D is resented in two forms, one for the consumption of alcohol (DÉBA‐A) and the other for the consumption pof drugs (DÉBA‐D).
id=241) Ref : http://www.intranetreseau.rtss.qc.ca/index.php?Ref : http://www.risqtoxico.ca/risq/www/deba.php) (( ASSESSMENT ADULTS ALCOHOL AND DRUGS 3) GAIN‐SS (Global Ap raisal of ndividual Needs – Mesure de dépistage GAIN – Short Screener) The 5‐minute GAIN‐SS is designed primarily for three things. First, it serves as a screener in general populations to quickly and accurately identify clients whom the full ~2‐hour GAIN–Initial would identify as having one or more behavioral health disorders (e.g., psychiatric disorders, substance use disorders, or crime or violence problems), which suggests the need for referral to some part of the behavioral health treatment system. Second, estimates of need from the GAIN‐SS can be used as a common metric across multiple systems or remote staff and as a denominator for quality assurance on the extent to which the rate of diagnoses/referrals are consistent with the estimated mix of problems from the GAIN‐SS. Such easures of quality assurance can be used for one‐on‐one supervision or performance‐based contracting.
e.
p I
mThird, it serves as a periodic measure of behavioral health change over tim Ref : http://www.chestnut.org/li/GAIN/GAIN_SS/GAIN‐SS_Manual.pdf) Ref : http://www.chestnut.org/LI/GAIN/GAIN_SS/GS_2.0.1‐English.pdf) (( ASSESSMENT YOUTHS ALCOHOL AND DRUGS ) DEP‐ADO Grille de dépistage de consommation problématique d’alcool et de drogues chez les 1 adolescents)
he DEP‐ADO was designed to identify the problematic use of alcohol and other drugs. It is made up of T
eight questions addressing frequency of use in the past 12 months, substance use in the past month, the age of initiation, injection drug use, number of five or more drinks in a single occasion in the past 30 days and last 12 months, the negative effects associated with substance abuse (six domains covered); and the frequency of cigarette use. It was developed in Quebec and was tested with a French‐speaking opulation, although an English‐language version is also available. The DEP‐ADO was designed for
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 3 of 21 Michel Perreault, principal investigator
pfrontline workers.
O.aspx) Ref: knowledgex.camh.net/.../Screening.../screening/screen.../DEP_ADRef : http://www.risqtoxico.ca/documents/DEP‐ADO_ang_V3_2.pdf) (( ASSESSMENT YOUTHS ALCOHOL AND DRUGS 2) IGT‐ADO (Indice de gravité d’une toxicomanie pour les adolescents) he IGT‐ADO is used to evaluate the severity of overconsumption of alcohol or drugs and related
ard the appropriate treatment. Tproblems for adolescents. It is also helpful to orient these adolescents tow
Réf : http://www.risqtoxico.ca/documents/Fiche_IGT_ADO_sep08.pdf) ( ASSESSMENT ADULTS ALCOHOL 1) AUDIT (Alcohol Use Disorders Identification Test) The AUDIT was developed by the World Health Organization (WHO) as a simple method of screening for excessive drinking and to assist in brief assessment. It can help identify excessive drinking as the cause of the presenting illness. It provides a framework for intervention to help risky drinkers reduce or cease lcohol consumption and thereby avoid the harmful consequences of their drinking. It also helps to
ful drinking. aidentify alcohol dependence and some specific consequences of harm
Ref : http://whqlibdoc.who.int/hq/2001/who_msd_msb_01.6a.pdf)(Ref : http://www.automesure.com/Pages/formulaire_alcool.html) ( ASSESSMENT ADULTS ALCOHOL 2) MAST (Michigan Alcoholism Screening Test) The MAST is one of the most widely used measures for assessing alcohol abuse. The measure is a 25‐item uestionnaire designed to provide a rapid and effective screening for lifetime alcohol‐related problems nd alcoholism. The MAST has been productively used in a variety of settings with varied populations. qa
Ref : http://pubs.niaaa.nih.gov/publications/assesing%20aRef : http://www.ncadd‐sfv.org/downloads/mast_test.pdf)
CMross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 4 of 21 ichel Perreault, principal investigator
((
lcohol/instrumentpdfs/42_mast.pdf)
ASSESSMENT ADULTS DRUGS 1) DAST‐20 (Drug Abuse Screening Test) The DAST‐20 is designed to provide a brief, simple, practical, but valid method for identifying individuals who are abusing psychoactive drugs and yield a quantitative index score of the degree of problems elated to drug use and misuse. This five‐minute questionnaire, used in an interview or self‐evaluation, rcan help gauge the severity of addiction to drugs other than alcohol.
buse_screening_test.html.) Ref: http://www.camh.net/publications/camh_publications/drug_aRef : http://www.emcdda.europa.eu/html.cfm/index3618EN.html) (( TREATMENT ADULTS ALCOHOL 1) Alcochoix+ Alcochoix+ is a secondary prevention program that aims to prevent the problem of alcohol consumption rom becoming more severe. It is a program that aims to control consumption by using different fapproaches in the treatment of alcohol use. Re : http://www.intranetreseau.rtss.qc.ca/index.php?id=241) ef: http://dependances.gouv.qc.ca/index.php?alcochoix_accueil) (R
SCREENING OF MENTAL HEALTH PROBLEMS GENERAL DISTRESS 1) K6 OR K10 These scales were designed to be sensitive around the threshold for the clinically significant range of the istribution of nonspecific distress in an effort to maximize the ability to discriminate cases of serious dmental illness (SMI) from non‐cases. Ref : http://www.hcp.med.harvard.edu/ncs/k6_scales.php) ((Ref:..http://www.hcp.med.harvard.edu/ncs/ftpdir/k6/K6+self%20admin‐3‐05‐%20FINAL.pdf) rench version: http://www.statcan.gc.ca/concepts/health‐sante/pdf/distress‐detresse‐fra.pdf (notez ue ce document est sous forme d’entrevue plutôt que de questionnaire) Fq
ross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 5 of 21 Michel Perreault, principal investigator
C
2) SF‐36 (Short Form (36) Health Survey) ualityMetric's SF‐36 Health Survey asks 36 questions to measure functional health and well‐being from Q
the patient's point of view. (Ref: http://www.qualitymetric.com/) 3) BASIS‐24 (Behavior And Symptom Identification Scale) The BASIS‐24 is designed for use by mental health providers, researchers, purchasers of mental health ervices, accreditation agencies, and internal quality assurance departments to measure the change in
mptom and problem difficulty over the course of treatment. sconsumer self‐reported sy
Ref : http://ebasis.org/) ( SPECIFIC DIMENSIONS ) PATIENT HE1 ALTH QUESTIONNAIRES, PHQ (Questionnaire de santé du patient, QSP) he Patient Health Questionnaire (PHQ) is a diagnostic tool for mental health disorders used by health Tcare professionals that is quick and easy for patients to complete.
x?Screener=01_PHQ) (Ref : http://www.phqscreeners.com/overview.asp 2) MOOD DISORDER QUESTIONNAIRE (MDQ) he Mood Disorder Questionnaire is a brief, self‐report screening instrument that can be used to identify Tpatients most likely to have bi‐ polar disorder Ref : http://www.dbsalliance.org/pdfs/MDQ.pdf) ((Ref : http://www.blackdoginstitute.org.au/healthprofessionals/resources/assessmenttools.cfm) rench version: Weber Rouget et al. (2005). Screening for bipolar disorders using a French version of the ood Disorder Questionnaire (MDQ). Journal of Affective Disorders, 88, 103–108.
FM
DIAGNOSIS OF MENTAL HEALTH AND/OR SUBSTANCE USE DISORDERS 1) MINI (Mini Internation l Neuropsychiatric Interview) he M.I.N.I. was designed as a brief structured interview for the major Axis I psychiatric disorders in
a
TDSM‐IV and ICD‐10.
Ref : https://www.medical‐outcomes.com/index.php) (
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 6 of 21 Michel Perreault, principal investigator
2) SCID‐I (Structured Clinical Interview for DSM‐IV Axis I disorders) The Structured Clinical Interview for DSM‐IV Axis I Disorders (SCID‐I) is a semi‐structured interview for making the major DSM‐IV Axis I diagnoses. The SCID‐II is a semi‐structured interview for making DSM‐IV
agnoses. Axis II: Personality Disorder di
Ref : http://www.scid4.org/) (
REFERENCES Boîte à outils en dépendances : http://www.intranetreseau.rtss.qc.ca/index.php?id=241 CAMH (2006). Méthodes de dépistage des troubles concomitants. www.camh.net Comité permanent sur les troubles concomitants de la Fédération québécoise des centres de réadaptation
es et autres toxicomanes (2008). Trousse de dépistage d’un trouble mental t un trouble lié à la consommation ou au jeu.
pour personnes alcooliquhez la clientèle présentanchttp://www.acrdq.qc.ca/ eady, M. (2009). A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol D
Settings. Network of Alcohol & other Drug Agencies. http://www.nada.org.au/
tèle adulte par les MSSS. Orientations relatives à l’organisation des soins et des services offerts à la clienquipes en santé mentale de première ligne en CSSS éhttp://publications.msss.gouv.qc.ca/acrobat/f/documentation/2011/11‐914‐01F.pdf
toxicomanie au Rouillard, P. (2004). Rôle des médecins dans le dépistage et l’intervention brève en uébec. Comité permanent de lutte à la toxicomanie. ttp://publications.msss.gouv.qc.ca/biblio/CPLT/publications/Role_medecinsVFweb.pdf Qh
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 7 of 21 Michel Perreault, principal investigator
EXAMPLES
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 8 of 21 Michel Perreault, principal investigator
http://www.partnersagainstpain.com/printouts/A7012DA4.pdf
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 9 of 21 Michel Perreault, principal investigator
http://www.who.int/substance_abuse/activities/assist_v3_english.pdf
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 10 of 21 Michel Perreault, principal investigator
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 11 of 21 Michel Perreault, principal investigator
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 12 of 21 Michel Perreault, principal investigator
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 13 of 21 Michel Perreault, principal investigator
http://www.risqtoxico.ca/risq/www/bref.php
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 14 of 21 Michel Perreault, principal investigator
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 15 of 21 Michel Perreault, principal investigator
http://www.chestnut.org/LI/GAIN/GAIN_SS/GS_2.0.1English.pdf
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 16 of 21 Michel Perreault, principal investigator
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 17 of 21 Michel Perreault, principal investigator
http://www.risqtoxico.ca/risq/www/bref.php
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 18 of 21 Michel Perreault, principal investigator
http://whqlibdoc.who.int/hq/2001/who_msd_msb_01.6a.pdf
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 19 of 21 Michel Perreault, principal investigator
http://www.ncaddsfv.org/symptoms/mast_test.html
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 20 of 21 Michel Perreault, principal investigator
DAST‐20http://www.ensuringsolutions.org/usr_doc/DAST.pdf
Cross‐training program for the South‐West of Montreal, June 1st, 2011 session Page 21 of 21 Michel Perreault, principal investigator
Accroché! Pas moi!
Ce questionnaire est confidentiel. Il est important que tu sois honnête envers toi-même. Ce questionnaire a pour but de t’aider à prendre conscience des changements de
comportement qui sont liés à ta consommation.
Si tu as de la difficulté à choisir entre le « oui » et le « non », choisis la réponse qui correspond généralement à la façon dont tu te sens.
Oui (√) Non (√)
1. Est-ce que la plupart de tes amis boivent ou consomment de la drogue? □ □
2. Évites-tu les personnes qui n’approuvent pas ta consommation? □ □
3. As-tu l’impression d’avoir utilisé une drogue juste pour avoir du plaisir? □ □
4. La drogue a-t-elle affecté ton rendement à l’école? Dans ton rapport avec □ □ les autres?
5. Les choses qui comptaient beaucoup avant te semblent-elles moins intéressantes? □ □
6. Dois-tu consommer plus qu’au début pour obtenir un effet? □ □
7. Utilises-tu de la drogue lorsque tu es tendu, déprimé ou pour t’aider à faire □ □ face aux situations déplaisantes?
8. Passes-tu beaucoup de temps à penser à ton prochain « high » (high veut □ □ dire « trip », « brosse », etc.)?
9. As-tu déjà fait quelque chose dont tu as honte à cause des drogues? □ □
10. Gardes-tu de la drogue en réserve afin de ne pas paniquer si tu en manques? □ □
11. Quand tu penses à ce que tu as l’intention de faire au cours de la journée ou de □ □ la semaine, s’agit-il généralement d’activités où il est possible de consommer de la drogue?
12. T’arrive-t-il de consommer plus que tu l’avais prévu? □ □
13. As-tu déjà essayé d’arrêter de consommer et tu as recommencé par la suite? □ □
14. As-tu déjà été incommodé physiquement ou émotivement lorsque tu as essayé □ □ d’arrêter de consommer?
15. T’es-tu déjà menti à toi-même ou as-tu déjà menti aux autres concernant la □ □ quantité et le type de drogue que tu consommes?
16. As-tu déjà volé quelqu’un pour obtenir de la drogue? □ □
17. Consommes-tu lorsque tu es seul? □ □